Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States.
Cano Garcia C, Nimer N, Piccinelli ML, Tappero S, Panunzio A, Barletta F, Incesu RB, Tian Z, Saad F, Kapoor A, Briganti A, Terrone C, Shariat SF, Tilki D, Antonelli A, De Cobelli O, Kluth LA, Becker A, Chun FKH, Karakiewicz PI. Cano Garcia C, et al. Among authors: incesu rb. Ann Epidemiol. 2023 Mar;79:65-70. doi: 10.1016/j.annepidem.2023.01.003. Epub 2023 Jan 11. Ann Epidemiol. 2023. PMID: 36640918
Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages.
Cano Garcia C, Panunzio A, Tappero S, Piccinelli ML, Barletta F, Incesu RB, Law KW, Scheipner L, Tian Z, Saad F, Shariat SF, Tilki D, Briganti A, De Cobelli O, Terrone C, Antonelli A, Banek S, Kluth LA, Chun FKH, Karakiewicz PI. Cano Garcia C, et al. Among authors: incesu rb. Medicina (Kaunas). 2023 Feb 24;59(3):451. doi: 10.3390/medicina59030451. Medicina (Kaunas). 2023. PMID: 36984452 Free PMC article.
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.
Panunzio A, Barletta F, Tappero S, Cano Garcia C, Piccinelli M, Incesu RB, Law KW, Tian Z, Tafuri A, Tilki D, De Cobelli O, Chun FKH, Terrone C, Briganti A, Saad F, Shariat SF, Bourdeau I, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: incesu rb. J Surg Oncol. 2023 Mar;127(4):560-567. doi: 10.1002/jso.27161. Epub 2022 Nov 26. J Surg Oncol. 2023. PMID: 36434748
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages.
Cano Garcia C, Barletta F, Incesu RB, Piccinelli ML, Tappero S, Panunzio A, Tian Z, Saad F, Shariat SF, Antonelli A, Terrone C, De Cobelli O, Graefen M, Tilki D, Briganti A, Wenzel M, Banek S, Kluth LA, Chun FKH, Karakiewicz PI. Cano Garcia C, et al. Among authors: incesu rb. Cancers (Basel). 2023 Jan 23;15(3):694. doi: 10.3390/cancers15030694. Cancers (Basel). 2023. PMID: 36765653 Free PMC article.
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
Cano Garcia C, Piccinelli ML, Tappero S, Panunzio A, Barletta F, Incesu RB, Tian Z, Saad F, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Antonelli A, De Cobelli O, Kosiba M, Banek S, Kluth LA, Chun FKH, Karakiewicz PI. Cano Garcia C, et al. Among authors: incesu rb. Int Urol Nephrol. 2023 May;55(5):1117-1123. doi: 10.1007/s11255-023-03517-0. Epub 2023 Feb 23. Int Urol Nephrol. 2023. PMID: 36813873
Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence.
Piccinelli ML, Panunzio A, Tappero S, Cano Garcia C, Barletta F, Incesu RB, Tian Z, Luzzago S, Mistretta FA, Ferro M, Saad F, Shariat SF, Tilki D, Briganti A, Chun FK, Terrone C, Antonelli A, DE Cobelli O, Musi G, Karakiewicz PI. Piccinelli ML, et al. Among authors: incesu rb. Minerva Urol Nephrol. 2023 Jun;75(3):319-328. doi: 10.23736/S2724-6051.23.05151-0. Minerva Urol Nephrol. 2023. PMID: 37221827 Free article.
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype.
Barletta F, Tappero S, Panunzio A, Incesu RB, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C, Antonelli A, Tilki D, Chun FKH, de Cobelli O, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: incesu rb. Cancers (Basel). 2022 Nov 23;14(23):5766. doi: 10.3390/cancers14235766. Cancers (Basel). 2022. PMID: 36497246 Free PMC article.
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy.
Cano Garcia C, Wenzel M, Piccinelli ML, Hoeh B, Landmann L, Tian Z, Humke C, Incesu RB, Köllermann J, Wild PJ, Würnschimmel C, Graefen M, Tilki D, Karakiewicz PI, Kluth LA, Chun FKH, Mandel P. Cano Garcia C, et al. Among authors: incesu rb. Diagnostics (Basel). 2023 May 3;13(9):1614. doi: 10.3390/diagnostics13091614. Diagnostics (Basel). 2023. PMID: 37175005 Free PMC article.
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma.
Piccinelli ML, Morra S, Tappero S, Cano Garcia C, Barletta F, Incesu RB, Scheipner L, Baudo A, Tian Z, Luzzago S, Mistretta FA, Ferro M, Saad F, Shariat SF, Carmignani L, Ahyai S, Tilki D, Briganti A, Chun FKH, Terrone C, Longo N, de Cobelli O, Musi G, Karakiewicz PI. Piccinelli ML, et al. Among authors: incesu rb. Cancers (Basel). 2023 Apr 5;15(7):2155. doi: 10.3390/cancers15072155. Cancers (Basel). 2023. PMID: 37046815 Free PMC article.
63 results